FY2025 · period end Dec '25 · from the 10-K filed Mar 3, 2026
Data as filed with the SEC, provided for information only — not investment advice.
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $88.24B | $89.45B | $79.74B | $79.71B | $72.85B |
| Gross Profit | $45.38B | $45.84B | $40.45B | $39.29B | $37.19B |
| Operating Income | $23.32B | $21.80B | $18.83B | $17.69B | $17.08B |
| Net Income | — | — | — | — | — |
| EPS (Diluted) | $0.99 | $0.91 | $0.92 | $0.91 | $0.80 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $145.09B | $162.51B | $132.64B | $137.96B | $138.60B |
| Total Liabilities | $56.31B | $62.93B | $52.50B | $54.63B | $54.58B |
| Stockholders' Equity | $88.77B | $99.58B | $80.14B | $83.33B | $84.02B |
| Cash & Equivalents | $18.64B | $28.60B | $16.06B | $14.93B | $16.63B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $24.45B | $26.10B | $24.71B | $20.64B | $22.90B |
| Capital Expenditures | $4.59B | $4.75B | $6.00B | $6.53B | $7.68B |
| Free Cash Flow | $19.86B | $21.35B | $18.71B | $14.11B | $15.22B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 51.4% | 51.2% | 50.7% | 49.3% | 51.1% |
| Operating Margin | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% |
| Net Margin | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% |
| Return on Equity | 38.0% | 38.9% | 39.6% | 38.5% | 39.1% |
| Return on Assets | 23.3% | 23.7% | 23.9% | 23.3% | 23.6% |
| Debt / Equity | 0.03× | 0.02× | 0.03× | 0.03× | 0.03× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or full history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 20-F | 0001292814-26-000640 | Dec 31, 2025 | Mar 3, 2026 | Mar 3, 2026 21:25 UTC | EDGAR |
| 20-F | 0001292814-25-000831 | Dec 31, 2024 | Mar 12, 2025 | Mar 12, 2025 21:16 UTC | EDGAR |
| 20-F | 0001292814-24-000771 | Dec 31, 2023 | Mar 11, 2024 | Mar 11, 2024 21:02 UTC | EDGAR |
| 20-F | 0001292814-23-000992 | Dec 31, 2022 | Mar 17, 2023 | Mar 17, 2023 21:09 UTC | EDGAR |
| 20-F | 0001171843-22-001985 | Dec 31, 2021 | Mar 18, 2022 | Mar 18, 2022 21:01 UTC | EDGAR |
| 20-F | 0001292814-21-001039 | Dec 31, 2020 | Mar 22, 2021 | Mar 19, 2021 21:35 UTC | EDGAR |
| 20-F | 0001292814-20-000888 | Dec 31, 2019 | Mar 24, 2020 | Mar 23, 2020 23:22 UTC | EDGAR |
| 20-F | 0001292814-19-000845 | Dec 31, 2018 | Mar 22, 2019 | Mar 22, 2019 21:21 UTC | EDGAR |
Direct links to SEC EDGAR. ABEV has additional filings available on the SEC site.
6 numbers AMBEV S.A. later changed — same XBRL tag, both filings linked.
TotalLiabilities·As of Dec 31, 2018
Notable restatementwas36.6BBRL
Revised up in a 20-F.
OperatingCashFlow·FY 2018
Notable restatementwas17.9BBRL
Revised up in a 20-F. Any P/OCF built on the original was 2.4% too high.
TotalAssets·As of Dec 31, 2017
Notable restatementwas86.9BBRL
Revised up in a 20-F.
OperatingCashFlow·FY 2017
Notable restatementwas17.9BBRL
Revised up in a 20-F. Any P/OCF built on the original was 2.1% too high.
GrossProfit·FY 2019
Minor restatementwas30.9BBRL
Revised down in a 20-F.
TotalAssets·As of Dec 31, 2018
Minor restatementwas94.1BBRL
Revised up in a 20-F.
ABEV is not the only one.
See every restatement we've found across the market — or get an alert the next time ABEV revises a number.
Restatements are detected by comparing every vintage of a fact across all of AMBEV S.A.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ABEV's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling AMBEV S.A. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ABEV yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on ABEV and publish the result to your public profile.
Ask about AMBEV S.A.
Continue in Workspace — cited answers on ABEV, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate, with delisted companies kept in.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs